参考文献
[1] Swaye PS, Fisher LD, Litwin P, et al. Aneurysmal coronary artery disease[J]. Circulation,1983,67(1):134-138. DOI: 10.1161/01.cir.67.1.134.
[2] Hartnell GG, Parnell BM, Pridie RB. Coronary artery ectasia. Its prevalence and clinical significance in 4993 patients[J]. Br Heart J, 1985,54(4):392-395. DOI: 10.1136/hrt.54.4.392.
[3] Manginas A, Cokkinos DV. Coronary artery ectasias: imaging, functional assessment and clinical implications[J]. Eur Heart J, 2006,27(9):1026-1031. DOI: 10.1093/eurheartj/ehi725.
[4] Ramappa P, Kottam A, Kuivanemi H, et al. Coronary artery ectasia-is it time for a reappraisal?[J]. Clin Cardiol, 2007,30(5):214-217. DOI: 10.1002/clc.20002.
[5] Nichols L, Lagana S, Parwani A. Coronary artery aneurysm: a review and hypothesis regarding etiology[J]. Arch Pathol Lab Med, 2008,132(5):823-828. DOI: 10.5858/2008-132-823-CAAARA.
[6] Crawley PD, Mahlow WJ, Huntsinger DR, et al. Giant coronary artery aneurysms: review and update[J]. Tex Heart Inst J, 2014,41(6):603-608. DOI: 10.14503/THIJ-13-3896.
[7] Liu R, Chen L, Wu W, et al. Neutrophil serine proteases and their endogenous inhibitors in coronary artery ectasia patients[J]. Anatol J Cardiol, 2016,16(1):23-28. DOI: 10.5152/akd.2015.6072.
[8] Guo Y, Liu R, Chen L, et al. Neutrophil activation and neutrophil derived neutrophil extracellular trap formation in patients with coronary artery ectasia[J]. BMC Cardiovasc Disord, 2020,20(1):101. DOI: 10.1186/s12872-020-01398-0.
[9] Liu R, Wu W, Chen L, et al. Transcriptional expression profiles of the main proteinases and their regulators in coronary artery ectasia patients’ mononuclear cells[J]. Acta Cardiol, 2016,71(2):157-163. DOI: 10.2143/AC.71.2.3141845.
[10] Liu R, Chen L, Wu W, et al. Extracellular matrix turnover in coronary artery ectasia patients[J]. Heart Vessels, 2016,31(3):351-359. DOI: 10.1007/s00380-014-0622-4.
[11] Antoniadis AP, Chatzizisis YS, Giannoglou GD. Pathogenetic mechanisms of coronary ectasia[J]. Int J Cardiol, 2008,130(3): 335-343. DOI: 10.1016/j.ijcard.2008.05.071.
[12] Koc F, Ardic I, Erdem S, et al. Relationship between L-arginine/asymmetric dimethylarginine, homocysteine, folic acid, vitamin B levels, and coronary artery ectasia[J]. Coron Artery Dis, 2010,21(8):445-449. DOI: 10.1097/MCA.0b013e32833fd22b.
[13] Wu D, Wang S, Xie J, et al. Hemodynamic mechanism of coronary artery aneurysm high occurrence on right coronary artery[J]. Front Physiol, 2020,11:323. DOI: 10.3389/fphys.2020.00323.
[14] Pham V, Hemptinne Q, Grinda JM, et al. Giant coronary aneurysms, from diagnosis to treatment: a literature review[J]. Arch Cardiovasc Dis, 2020,113(1):59-69. DOI: 10.1016/j.acvd.2019.10.008.
[15] Chen H, Zhang Y, Li C, et al. Coronary involvement in patients with Behçet’s disease[J]. Clin Rheumatol, 2019,38(10):2835-2841. DOI: 10.1007/s10067-019-04640-z.
[16] McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association[J]. Circulation, 2017,135(17):e927-e999. DOI: 10.1161/CIR.0000000000000484.
[17] Sandhu VK, Wei J, Thomson L, et al. Five-year follow-up of coronary microvascular dysfunction and coronary artery disease in systemic lupus erythematosus: results from a community-based lupus cohort[J]. Arthritis Care Res(Hoboken), 2020,72(7):882-887. DOI: 10.1002/acr.23920.
[18] Dede O, Varol E, Altinbas A, et al. Chronic fluoride exposure has a role in etiology of coronary artery ectasia: sialic acid/glycosaminoglycan ratio[J]. Biol Trace Elem Res, 2011,143(2):695-701. DOI: 10.1007/s12011-010-8913-9.
[19] Nicholson GT, Hsu DT, Colan SD, et al. Coronary artery dilation in sickle cell disease[J]. J Pediatr, 2011,159(5):789-794. DOI: 10.1016/j.jpeds.2011.05.013.
[20] Kawsara A, Núñez Gil IJ, Alqahtani F, et al. Management of coronary artery aneurysms[J]. JACC Cardiovasc Interv, 2018,11(13):1211-1223. DOI: 10.1016/j.jcin.2018.02.041.
[21] Markis JE, Joffe CD, Cohn PF, et al. Clinical significance of coronary arterial ectasia[J]. Am J Cardiol, 1976,37(2):217-222. DOI: 10.1016/0002-9149(76)90315-5.
[22] Farrag A, Faramawy AE, Salem MA, et al. Coronary artery ectasia diagnosed using multidetector computed tomography: morphology and relation to coronary artery calcification[J]. Int J Cardiovasc Imaging, 2013,29(2):427-433. DOI: 10.1007/s10554-012-0079-4.
[23] 蒋晓威 , 乔树宾 . 冠状动脉扩张症的研究及治疗进展 [J]. 中华心血管病杂志, 2018, 46(10): 821-824. DOI: 10.3760/cma.j. issn.0253-3758.2018.10.011.
[24] Doi T, Kataoka Y, Noguchi T, et al. Coronary artery ectasia predicts future cardiac events in patients with acute myocardial infarction[J]. Arterioscler Thromb Vasc Biol, 2017,37(12):2350-2355. DOI: 10.1161/ATVBAHA.117.309683.
[25] Wu W, Zhang S, Guo Y, et al. Correlation of increased corrected TIMI frame counts and the topographical extent of isolated coronary artery ectasia[J]. BMC Cardiovasc Disord, 2018,18(1):102. DOI: 10.1186/s12872-018-0833-1.
[26] Wu W, Liu R, Chen L, et al. Disequilibrium of blood coagulation and fibrinolytic system in patients with coronary artery ectasia[J]. Medicine (Baltimore), 2016,95(8):e2779. DOI: 10.1097/MD.0000000000002779.
[27] Tremoulet AH, Jain S, Jone PN, et al. Phase I/IIa trial of atorvastatin in patients with acute Kawasaki disease with coronary artery aneurysm[J]. J Pediatr, 2019,215:107-117.e12. DOI: 10.1016/j.jpeds.2019.07.064.
[28] Kim W, Jeong MH, Ahn YK, et al. The changes of fractional flow reserve after intracoronary nitrate and Nicorandil injection in coronary artery ectasia[J]. Int J Cardiol, 2006,113(2):250-251. DOI: 10.1016/j.ijcard.2005.08.055.
[29] Núñez-Gil IJ, Cerrato E, Bollati M, et al. Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR)[J]. Int J Cardiol, 2020,299:49-55. DOI: 10.1016/j.ijcard.2019.05.067.
[30] 乔树宾 , 李佳 , 崔锦钢 , 等 . 裸金属支架治疗单支冠状动脉局限性动脉瘤合并严重狭窄的效果 [J]. 中华心血管病杂志,2018,46(4):279-283. DOI: 10.3760/cma.j.issn.0253-3758. 2018.04.006.